Team

About Arialys Therapeutics

Arialys Therapeutics is a private biotech company founded by Avalon BioVentures, Catalys Pacific, and MPM Capital. Our experienced internal team is focused on clinical evaluation of ART5803 while also partnering with our scientific and clinical key opinion leaders to explore the untapped potential of autoimmune modulation in broader neuropsychiatric diseases.

Clinical Advisory Board

Chairperson

Marty Jefson, PhD

EVP, Corporate Strategy, Arialys Therapeutics

Divyanshu (Div) Dubey, MBBS

Associate Professor of Neurology, and Laboratory Medicine and Pathology at Mayo Clinic

Jeffrey M. Gelfand, MD

Associate Professor, Neurology at UCSF Weill Institute for Neurosciences

Mark P. Gorman, MD

Director Pediatric Neuro-immunology Center, Boston Children's Hospital

Benjamin M. Greenberg, MD, MHS

Vice Chair of Clinical and Translational Research for the Department of Neurology at UTSW

Elizabeth Ann Molloy Wells, MD, MHS

Vice President of the Neuroscience and Behavioral Medicine Center at Children’s National Hospital

Prof Marion Leboyer, MD, PhD

Chair of the Department of Psychiatry, University Paris Est Creteil, Head of the Psychiatry and Addictology Unit, Hôpitaux Universitaires Henri Mondor

Prof Belinda Lennox, DM, FRCPsych

Head of Department, Professor of Psychiatry, University of Oxford, UK

Sean J. Pittock, MD

Director of Mayo Clinic's Neuroimmunology Laboratory and Center for MS and Autoimmune Neurology

Thomas Pollak, PhD, MRCPsych

Senior Clinical Lecturer, Honorary Consultant Neuropsychiatrist, King’s College London, UK

Prof Harald Pruess, MD

Director Department of Experimental Neurology, Charite Universitatsmedizen Berlin, Germany

Prof Ludger Tabartz van Elst, MD

Professor for Psychiatry and Psychotherapy, University Medical Center Freiburg, Germany

Team

About Arialys Therapeutics

Leadership

Board of Directors

Jay Lichter, PhD

Peter Flynn, PhD

Ed Hurwitz, JD, MBA

BT Slingsby, MD, PhD, MPH

Asish K. Xavier, PhD

Clinical Advisory Board

Marty Jefson, PhD

Divyanshu (Div) Dubey, MBBS

Jeffrey M. Gelfand, MD

Mark P. Gorman, MD

Benjamin M. Greenberg, MD, MHS

Elizabeth Ann Molloy Wells, MD, MHS

Prof Marion Leboyer, MD, PhD

Prof Belinda Lennox, DM, FRCPsych

Sean J. Pittock, MD

Thomas Pollak, PhD, MRCPsych

Prof Harald Pruess, MD

Prof Ludger Tabartz van Elst, MD

Investors

Follow us

Team

About Arialys Therapeutics

Leadership

Board of Directors

Jay Lichter, PhD

Peter Flynn, PhD

Ed Hurwitz, JD, MBA

BT Slingsby, MD, PhD, MPH

Asish K. Xavier, PhD

Clinical Advisory Board

Marty Jefson, PhD

Divyanshu (Div) Dubey, MBBS

Jeffrey M. Gelfand, MD

Mark P. Gorman, MD

Benjamin M. Greenberg, MD, MHS

Elizabeth Ann Molloy Wells, MD, MHS

Prof Marion Leboyer, MD, PhD

Prof Belinda Lennox, DM, FRCPsych

Sean J. Pittock, MD

Thomas Pollak, PhD, MRCPsych

Prof Harald Pruess, MD

Prof Ludger Tabartz van Elst, MD

Investors

Sign up for news updates

Follow us